Sci Simple

New Science Research Articles Everyday

# Health Sciences # Genetic and Genomic Medicine

RNA Sequencing: A Deep Dive into Health Insights

Understanding RNA sequencing's role in disease detection and patient care.

Jingni He, Devika Ganesamoorthy, Jessie J-Y Chang, Josh Zhang, Sharon L Trevor, Kristen S Gibbons, Stephen J McPherson, Jessica C. Kling, Luregn J Schlapbach, Antje Blumenthal, Lachlan JM Coin

― 7 min read


RNA Sequencing's Impact RNA Sequencing's Impact on Health through advanced RNA analysis. Revolutionizing disease research
Table of Contents

When doctors try to figure out what's wrong with a patient, they often look at their blood. One way to get insights into health issues is through RNA sequencing. This technique allows scientists to study the RNA in our cells, which can provide clues about how diseases behave in the body.

What is RNA?

RNA, or ribonucleic acid, is a molecule that plays a key role in our bodies. Imagine it as a messenger that carries instructions from our DNA to make proteins, which are essential for our cells to function. When something goes wrong, like during an infection, the kind and amount of RNA produced can change.

Why Use RNA Sequencing?

Researchers use RNA sequencing to learn more about these changes. It helps them see how genes are turned on or off in response to diseases. By analyzing RNA, scientists can spot which genes are active in a patient and better understand their health condition.

The Role of Transcriptomics

Transcriptomics is a fancy word for studying RNA. This field focuses on how RNA molecules are expressed in different situations, such as when someone is sick. By looking at these differences, researchers can gain insights into disease mechanisms, which could lead to better treatments and diagnostics.

Different Methods of RNA Sequencing

One popular method for RNA sequencing is known as short-read sequencing. This method captures small pieces of RNA and reads them to determine what's going on in a patient's body. It’s like reading a few words from a book instead of the whole story. While this technique is widely used and provides a lot of data, it has some limitations.

The Downside of Short-Read Sequencing

Short-read sequencing can introduce biases, or mistakes, in understanding the full picture of RNA expression. For example, if a gene has multiple variations—like different endings—it can be tricky to tell them apart. Also, the method may not accurately represent longer RNA molecules or variations in how RNA is processed after it's made. Think of it like trying to understand a song by only listening to a few notes; you might miss the whole melody.

A New Approach: Nanopore Sequencing

Nanopore sequencing is an innovative method that's making waves. It reads the entire length of RNA molecules, allowing researchers to capture a more complete picture of how genes are expressed. Imagine reading the whole book at once instead of just snippets. This can uncover new RNA variations that short-read methods might miss.

Advantages of Nanopore Sequencing

  1. Full-Length Reads: Since it reads longer segments of RNA, it can provide more information about different gene variants.
  2. Direct Analysis: It examines RNA directly, avoiding biases related to preparing complementary DNA (cDNA), which is necessary in short-read sequencing.
  3. Poly(A) Tail Length Measurement: Nanopore sequencing can measure the length of poly(A) tails, which are essential for regulating how long RNA lasts in our cells. This can give clues about which genes are functioning well or poorly.

Investigating RNA in Infection

Researchers are particularly interested in how RNA behaves when the body is fighting infections, like bacterial or viral attacks. By studying RNA from patients with infections, they can see how the body reacts and which genes are active.

The Study of Sepsis

Sepsis is a serious condition that occurs when the body has a severe response to infection. In a recent study, RNA from the blood of patients with suspected sepsis was analyzed using both short-read and nanopore sequencing. This comparison aimed to find out how well these methods could agree with each other and which might provide more valuable insights.

Comparing Methods

The researchers found that the results from both sequencing methods were generally good, with many similar findings. However, they also noticed that nanopore sequencing could reveal additional information, especially regarding RNA length and variations.

Gene Expression Correlation

In comparing the RNA expression data, they observed a strong correlation between the two methods, particularly when using specific tools for analysis. However, while the overall gene expression looked similar, differences cropped up when examining individual RNA molecules, especially concerning their lengths and structures.

Poly(A) Tail Lengths: What Do They Mean?

The length of the poly(A) tail on RNA molecules matters. Shorter poly(A) tails can signal that RNA is about to break down, while longer tails might suggest that RNA is stable and being translated into proteins. This aspect was explored in the study, revealing that various genes had distinct poly(A) tail lengths depending on whether an infection was viral or bacterial.

Findings on Poly(A) Tails

The study showed that mitochondrial RNA molecules tended to have shorter poly(A) tails, while RNA from the nucleus exhibited a broader range of lengths. This suggests that different sources of RNA in the body might behave differently when it comes to stability and how they function within the cells.

Discovering New RNA Variants

One of the exciting parts of using nanopore sequencing is the chance to discover novel RNA isoforms. In the study, researchers found many new variants that hadn’t been seen before. These novel isoforms might play essential roles in health and disease, and their discovery could open up new avenues for understanding how diseases develop.

Implications for Biomarker Discovery

Identifying various RNA forms could help researchers find biomarkers, which are indicators of disease. By understanding these markers, doctors may be able to diagnose conditions earlier or tailor treatments to individual patients more effectively.

Polyadenylation as a Disease Marker

The study highlighted that changes in poly(A) tail lengths may be linked to disease. Researchers observed differences in polyadenylation patterns between patients with bacterial and viral infections. This suggests that monitoring these patterns could be a helpful way to distinguish between types of infections and possibly improve treatment strategies.

Uncovering Differential Transcript Usage

Another intriguing aspect of the study was the examination of how different RNA transcripts are used in response to infections. Researchers looked at cases where the proportion of different RNA forms changed when patients had bacterial versus viral infections.

Importance of Differential Transcript Usage

Understanding these shifts might help illuminate how the body responds to different pathogens. In some cases, even when overall gene expression looks similar, the specific usage of different RNA forms can tell a more detailed story about the immune response.

Challenges and Future Directions

While the advantages of nanopore sequencing are clear, this method isn't perfect and comes with its challenges. The technology currently offers lower throughput compared to traditional methods, making it less practical for large-scale studies. Additionally, the tools for analyzing nanopore data are still developing.

Looking Ahead

Researchers are optimistic about the future of RNA sequencing. Continuous improvements in technology and data analysis should make it even easier to use these methods in clinical settings. As they learn more about RNA and its role in diseases, this work could lead to better diagnostics and treatments for various health conditions.

Conclusion: The Future of RNA Research

The world of RNA sequencing is dynamic and rapidly evolving. By harnessing the power of new technologies like nanopore sequencing, researchers are working toward a deeper understanding of how our bodies respond to diseases. This knowledge could ultimately improve patient care and lead to more effective treatments.

So the next time you hear about RNA sequencing, remember—it's not just science; it's a window into the workings of our bodies, with the potential to change how we approach health and illness. And who knows? Maybe one day, we'll be sequencing RNA while eating breakfast, just like checking the weather—after all, it’s a rather important part of our daily lives!

Original Source

Title: Utilising Nanopore direct RNA sequencing of blood from patients with sepsis for discovery of co- and post-transcriptional disease biomarkers

Abstract: BackgroundRNA sequencing of whole blood has been increasingly employed to find transcriptomic signatures of disease states. These studies traditionally utilize short-read sequencing of cDNA, missing important aspects of RNA expression such as differential isoform abundance and poly(A) tail length variation. MethodsWe used Oxford Nanopore Technologies long-read sequencing to sequence native mRNA extracted from whole blood from 12 patients with suspected bacterial and viral sepsis, and compared with results from matching Illumina short-read cDNA sequencing data. Additionally, we explored poly(A) tail length variation, novel transcript identification and differential transcript usage. ResultsThe correlation of gene count data between Illumina cDNA and Nanopore RNA-sequencing strongly depended on the choice of analysis pipeline; NanoCount for Nanopore and Kallisto for Illumina data yielded the highest mean Pearsons correlation of 0.93 at gene level and 0.74 at transcript isoform level. We identified 18 genes significantly differentially polyadenylated and 4 genes with significant differential transcript usage between bacterial and viral infection. Gene ontology gene set enrichment analysis of poly(A) tail length revealed enrichment of long tails in signal transduction and short tails in oxidoreductase molecular functions. Additionally, we detected 594 non-artifactual novel transcript isoforms, including 9 novel isoforms for Immunoglobulin lambda like polypeptide 5 (IGLL5). ConclusionsNanopore RNA- and Illumina cDNA-gene counts are strongly correlated, indicating that both platforms are suitable for discovery and validation of gene count biomarkers. Nanopore direct RNA-seq provides additional advantages by uncovering additional post- and co-transcriptional biomarkers, such as poly(A) tail length variation and transcript isoform usage.

Authors: Jingni He, Devika Ganesamoorthy, Jessie J-Y Chang, Josh Zhang, Sharon L Trevor, Kristen S Gibbons, Stephen J McPherson, Jessica C. Kling, Luregn J Schlapbach, Antje Blumenthal, Lachlan JM Coin

Last Update: 2024-12-14 00:00:00

Language: English

Source URL: https://www.medrxiv.org/content/10.1101/2024.12.13.24318230

Source PDF: https://www.medrxiv.org/content/10.1101/2024.12.13.24318230.full.pdf

Licence: https://creativecommons.org/licenses/by/4.0/

Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.

Thank you to medrxiv for use of its open access interoperability.

More from authors

Similar Articles